Samba Reddy, PhD, RPh, professor in the department of Neuroscience and Experimental Therapeutics at Texas A&M College of Medicine, has been named a Fellow of the American Epilepsy Society (FAES), a lifetime professional honor in recognition of his accomplishments and dedication to excellence in epilepsy in the United States and all over the world.
Epilepsy is a chronic brain disease affecting nearly 65 million people worldwide, including 3 million Americans. People with epilepsy experience devastating seizures and often have debilitating side effects from them. Reddy’s scientific research over the past 20 years is translational—meaning it goes into real interventions—and is currently helping thousands of patients.
“Dr. Reddy’s commitment to the epilepsy community and the American Epilepsy Society are commendable,” said Michael D. Privitera, MD, president of American Epilepsy Society. “Thanks to his efforts and leadership, we collectively are able to advance the science and care for people with epilepsy.”
Reddy was inducted with honors into the FAES class on December 3, 2016 at the American Epilepsy Society Annual Meeting in Houston, Texas, which was the largest meeting on epilepsy in the world, attended by more than 5000 delegates and neurologists from many countries. The FAES credential is peer recognition that demonstrates professional accomplishment and dedication in epilepsy. “The Texas A&M College of Medicine is pleased and proud of Dr. Reddy’s ‘hat trick’: three major fellowship awards from three major national professional societies in three consecutive years: the American Association of Pharmaceutical Scientists in 2014, the American Association for the Advancement of Science in 2015, and now the American Epilepsy Society in 2016,” said William Griffith, PhD, professor and chair of the Department of Neuroscience and Experimental Therapeutics. “This is quite an accomplishment. We appreciate such laurels that would have such a positive impact in our department, college and university.”
Reddy is a distinguished pharmacologist with over 160 scientific publications. His research has been continuously funded by the National Institutes of Health (NIH) for over 12 years. Recently, he won a major grant from the Department of Defense (DOD) to find treatments for seizures after traumatic brain injury.
“Reddy is a rising star at A&M, and the emergent impact of his translational research could make him a prospective candidate for the National Academy nomination,” said Van Wilson, PhD, associate dean for Research and Graduate Studies at College of Medicine.